الفهرس | Only 14 pages are availabe for public view |
Abstract Acute ALP poisoning is a major health problem with serious outcomes. It is becoming more common in Egypt due to its frequent usage as a suicide poison. This suicidal usage is encouraged by its low cost and widespread accessibility. The risk of phosphide-related mortality in humans ranges from 30 to 100 %. There is no clear antidote to ALP poisoning and therefore, to date, various modalities have been proposed for treatment. Cardiocirculatory failure and metabolic acidosis are perhaps the most significant factors that do not respond to traditional therapies. Consequently, new therapeutic methods must be evaluated to reduce mortality and/or morbidity rates. Therefore, the aim of this study was to evaluate the safety and efficacy of insulin-euglycemia therapy in management of patients with acute aluminum phosphide poisoning. |